Deutsche Bank
PCVX icon

Deutsche Bank’s Vaxcyte PCVX Stock Holding History

Deutsche Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Sell
258,338
-41,355
-14% -$2.25M ﹤0.01% 934
2026
Q1 		$17.4M Sell
299,693
-43,201
-13% -$2.35M 0.01% 895
2025
Q4 		$15.8M Sell
342,894
-54,895
-14% -$2.46M 0.01% 945
2025
Q3 		$14.3M Buy
397,789
+134,832
+51% +$4.47M ﹤0.01% 938
2025
Q2 		$8.55M Sell
262,957
-934,731
-78% -$30.6M ﹤0.01% 1046
2025
Q1 		$45.2M Sell
1,197,688
-15,018
-1% -$1.2M 0.02% 643
2024
Q4 		$99.3M Buy
1,212,706
+64,522
+6% +$6.41M 0.04% 433
2024
Q3 		$131M Buy
1,148,184
+1,018,122
+783% +$91.8M 0.05% 331
2024
Q2 		$9.82M Sell
130,062
-6,086
-4% -$414K ﹤0.01% 1013
2024
Q1 		$9.3M Sell
136,148
-16,110
-11% -$1.12M ﹤0.01% 1051
2023
Q4 		$9.56M Buy
152,258
+77,179
+103% +$4.01M ﹤0.01% 1017
2023
Q3 		$3.83M Buy
75,079
+32,099
+75% +$1.58M ﹤0.01% 1113
2023
Q2 		$2.15M Sell
42,980
-6,549
-13% -$310K ﹤0.01% 1587
2023
Q1 		$1.86M Buy
49,529
+14,034
+40% +$595K ﹤0.01% 1728
2022
Q4 		$1.7M Buy
35,495
+11,668
+49% +$458K ﹤0.01% 1746
2022
Q3 		$572K Sell
23,827
-2,664
-10% -$67.5K ﹤0.01% 2298
2022
Q2 		$576K Buy
26,491
+2,205
+9% +$51K ﹤0.01% 2501
2022
Q1 		$587K Sell
24,286
-5,758
-19% -$126K ﹤0.01% 2652
2021
Q4 		$714K Buy
30,044
+1,368
+5% +$31.8K ﹤0.01% 2621
2021
Q3 		$727K Sell
28,676
-1,029
-3% -$24.9K ﹤0.01% 2808
2021
Q2 		$668K Buy
29,705
+10,545
+55% +$216K ﹤0.01% 3038
2021
Q1 		$378K Buy
19,160
+5,378
+39% +$135K ﹤0.01% 3272
2020
Q4 		$366K Buy
13,782
+4,045
+42% +$150K ﹤0.01% 3120
2020
Q3 		$481K Buy
+9,737
New +$388K ﹤0.01% 2659

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deutsche Bank's PCVX Position: Q2 2026 in Review

Deutsche Bank reduced its Vaxcyte (PCVX) stake by 14% in Q2 2026, selling an estimated $2.25M and leaving 258,338 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Deutsche Bank first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. The position peaked at $131M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Deutsche Bank held 258,338 shares of Vaxcyte worth $15M as of Q2 2026.
  • Deutsche Bank sold 41,355 Vaxcyte shares in Q2 2026, an estimated $2.25M.
  • Vaxcyte made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #934 holding.
  • Deutsche Bank first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • Deutsche Bank's Vaxcyte position peaked at $131M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.